In the latter, their presence in the PBMC correlated with the inability to respond to a vaccine based on the MUC1 antigen abnormally expressed on colonic polyps and colon cancer, which was being tested for colon cancer prevention (21). This evidence concerns the gene MUC1 and colon inflammatory polyp.